KOREAN DRUG CO., LTD.
Founded in 1980, Korean Drug produces the cold medicine Haben and the dementia drug Neuromed, along with other CNS disease treatments.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1980 and listed on KOSDAQ in 2000, Korean Drug is a pharmaceutical company. It produces and sells the cold medicine Haben and the dementia drug Neuromed, along with treatments for central nervous system (CNS) conditions including epilepsy, stroke, and Parkinson's disease, digestive and dermatological agents, antibiotics, and antipyretic/analgesic drugs. It has technology-transfer distribution and manufacturing agreements -- with Janssen-Cilag for Biafine Emulsion (1994) and with Gebro Pharma GmbH for Seractil Tablet (2002) -- and sells products through pharmacy, hospital, and clinic sales divisions as well as exports.
Products & technology
- HabenComprehensive cold medicine
- NeuromedDementia treatment
- Biafine EmulsionTechnology-transfer distribution product
- Seractil TabletTechnology-transfer manufacturing product
Regulatory approvals
data.go.kr174 Korean MFDS drug approvals · 1981–2025 / 1 Korean MFDS device approvals · 2014
- MFDS drugK-Terazan Tab 50mg2025-09-24Drug · Prescription · Approval202502530
- MFDS drugNEUROMAGMG SOLUTION2025-08-08Drug · OTC · Notification202502072
- MFDS drugNeurogoline Tab. 10mg2025-01-17Drug · Prescription · Approval202500138
- MFDS drugNEUROCEPT DUO Tab.2024-12-23Drug · Prescription · Approval202403048
- MFDS drugGinkgo-mexin Tab. 240mg2024-11-06Drug · OTC · Notification202402627
- MFDS drugNeurogoline Tab. 30mg2024-02-29Drug · Prescription · Approval202400421
- MFDS drugGINKOMAXAM DUO Capsule2023-11-10Drug · OTC · Notification202303115
- MFDS drugHaben Herb Gold Cap.2023-10-26Drug · OTC · Notification202302998
- MFDS drugAdmed Tab 20mg2023-06-27Drug · Prescription · Approval202301957
- MFDS drugHaben-Power Gold Cap.2023-03-14Drug · OTC · Notification202300909
- MFDS drugdapasulin Tablet 10mg2023-01-26Drug · Prescription · Approval202300341
- MFDS drugADMed tab. 5mg2022-01-11Drug · Prescription · Approval202200176
Show 68 more
- MFDS drugDMPENEU Tablet(Epalrestat)Revoked2021-12-03Drug · Prescription · Notification202107785
- MFDS drugXANET Tab. 20mg2021-04-23Drug · Prescription · Approval202103357
- MFDS drugXANET Tab. 15mg2021-04-06Drug · Prescription · Approval202102954
- MFDS drugXANET Tab. 10mg2021-04-06Drug · Prescription · Approval202102955
- MFDS drugHemen Stick2021-03-04Drug · OTC · Notification202102013
- MFDS drugLIPODUO Tab. 10/10mg2021-02-18Drug · Prescription · Approval202101545
- MFDS drugLIPODUO Tab. 10/20mg2021-02-18Drug · Prescription · Approval202101546
- MFDS drugHaben Cough S Sol.2020-12-18Drug · OTC · Notification202009037
- MFDS drugHaben S Sol.2020-12-17Drug · OTC · Notification202008963
- MFDS drugHaben Col S Sol.2020-12-16Drug · OTC · Notification202008854
- MFDS drugEXOXIUM Tab. 20mg2020-11-12Drug · Prescription · Approval202007779
- MFDS drugEXOXIUM Tab. 40mg2020-11-12Drug · Prescription · Approval202007780
- MFDS drugMulti-Q10HTtabletRevoked2020-07-21Drug · OTC · Notification202005215
- MFDS drugPeptis Tab.2020-03-12Drug · OTC · Notification202001730
- MFDS drugRagilen Tab.2019-12-31Drug · Prescription · Approval201908719
- MFDS drugRagilen Tab. 0.5mg2019-12-31Drug · Prescription · Approval201908720
- MFDS drugLevocombi S Solution2019-05-21Drug · OTC · Approval201903305
- MFDS drugCleartoc CreamRevoked2019-05-08Drug · OTC · Notification201902959
- MFDS drugRopimax PD Tab. 2mg2019-03-07Drug · Prescription · Approval201901411
- MFDS drugRopimax PD Tab. 4mg2019-03-07Drug · Prescription · Approval201901416
- MFDS drugRopimax PD Tab. 8mg2019-03-07Drug · Prescription · Approval201901417
- MFDS drugMulti-Q10 PLUS Tab.2018-11-14Drug · OTC · Notification201804518
- MFDS drugHaben Herb F Cap.Revoked2018-11-02Drug · OTC · Notification201804378
- MFDS drugVirax Clear Cream2018-06-28Drug · OTC · Approval201802687
- MFDS drugPregalin Cap. 25mg2018-05-30Drug · Prescription · Approval201802254
- MFDS drugPregalin Cap. 50mg2018-05-21Drug · Prescription · Approval201802138
- MFDS drugPregalin Cap. 300mg2018-02-26Drug · Prescription · Approval201800935
- MFDS drugSilyton Soft Cap.2018-02-26Drug · OTC · Notification201800933
- MFDS drugAmiprex Gold Tab.2018-01-23Drug · OTC · Notification201800317
- MFDS drugDimensta Tab.2018-01-12Drug · Prescription · Approval201800191
- MFDS drugDuocla Neo Dry Syrup2017-10-11Drug · Prescription · Notification201707368
- MFDS drugLinopostine Tab. 10mg2017-09-29Drug · Prescription · Approval201707335
- MFDS drugSolistop Tab. 5mg2017-07-19Drug · Prescription · Approval201705755
- MFDS drugSolistop Tab. 10mg2017-07-19Drug · Prescription · Approval201705756
- MFDS drugLaxarotin Tab. 100mg2017-06-13Drug · Prescription · Approval201703447
- MFDS drugLaxarotin Tab. 50mg2017-06-13Drug · Prescription · Approval201703448
- MFDS drugStroxstar ER Cap.Revoked2017-05-17Drug · Prescription · Approval201702431
- MFDS drugMemo-Q Sol.2016-09-06Drug · OTC · Notification201605441
- MFDS drugMulsto ODF2016-06-20Drug · OTC · Notification201603600
- MFDS drugRoicoby S Solution2016-04-20Drug · OTC · Approval201602206
- MFDS drugHabenplus Nasal Spray2016-04-14Drug · OTC · Notification201602094
- MFDS drugHaben Fresh Nasal Spray2016-03-14Drug · OTC · Notification201601470
- MFDS drugTurbina Plus Cream2016-01-05Drug · OTC · Notification201600079
- MFDS drugCollodem S Liquid2015-12-29Drug · OTC · Approval201508488
- MFDS drugPenstop Soft Cap.2015-10-12Drug · OTC · Notification201507100
- MFDS drugLiposto Tab. 5mg2015-09-30Drug · Prescription · Approval201506829
- MFDS drugLiposto Tab. 10mg2015-09-30Drug · Prescription · Approval201506830
- MFDS drugBronchamin Tab.2015-09-30Drug · Prescription · Notification201506845
- MFDS drugOlotension Tab. 5/20mg2015-08-25Drug · Prescription · Approval201505939
- MFDS drugOlotension Tab. 5/40mg2015-08-25Drug · Prescription · Approval201505940
- MFDS drugOlotension Tab. 10/40mg2015-08-25Drug · Prescription · Approval201505941
- MFDS drugNeurocept ODF 10Revoked2015-08-12Drug · Prescription · Approval201505588
- MFDS drugNeurocept ODF 5Revoked2015-08-12Drug · Prescription · Approval201505589
- MFDS drugSpamed Tab.2015-07-24Drug · OTC · Notification201505055
- MFDS drugLiposto Tab. 20mg2015-06-26Drug · Prescription · Approval201504162
- MFDS drugNeuroceltec Tab.2015-06-17Drug · OTC · Notification201503940
- MFDS drugCelbric Cap.2015-03-25Drug · Prescription · Approval201501572
- MFDSIVD strip for endocrine self testRevoked2014-11-25Product approval · Class 2제허 14-2432 호
- MFDS drugHaben-Co Tab.Revoked2014-11-05Drug · OTC · Notification201405163
- MFDS drugEsoroxen Tab.2014-08-12Drug · Prescription · Approval201403728
- MFDS drugKorean Drug Co. Cefaclor Cap.2014-05-23Drug · Prescription · Approval201402355
- MFDS drugDuroprex Cap. 30mg2014-04-14Drug · Prescription · Approval201401792
- MFDS drugRheumaclo Tab.2014-02-05Drug · Prescription · Approval201400500
- MFDS drugDuroprex Cap. 60mg2013-12-30Drug · Prescription · Approval201310933
- MFDS drugZainal-Q Soft Cap.2013-12-04Drug · OTC · Notification201310498
- MFDS drugHaben US Cap.2013-10-04Drug · OTC · Notification201309581
- MFDS drugBonehyal Plus Inj.Revoked2013-09-27Drug · Prescription · Notification201309477
- MFDS drugHaben Q Soft Cap.2013-04-11Drug · OTC · Notification201306861
Showing the 80 most recent of 175 records.
Clinical trials
data.go.kr18 MFDS clinical trial authorisations · 2013–2026 (Bioequivalence 17 · Phase 4 1)
- Phase 4큐업액2026-03-18
4 trial sites
- Bioequivalence자바닉스정60밀리그램2025-06-19
1 trial site
- Bioequivalence고려보노프라잔정20밀리그램(가칭)2024-08-21
1 trial site
- Bioequivalence고려테고프라잔50밀리그램(가칭)2024-01-03
1 trial site
- Bioequivalence고려니세르골린(가칭)2023-04-20
1 trial site
- Bioequivalence리포메트정20밀리그램2021-11-23
1 trial site
- Bioequivalence자네트정20밀리그램2020-04-22
1 trial site
- Bioequivalence자네트정20밀리그램2019-10-15
1 trial site
- Bioequivalence고려라사길린정(가칭)2019-04-15
2 trial sites
- Bioequivalence로피맥스피디정2밀리그램(로피니롤염산염)2017-05-30
2 trial sites
- Bioequivalence고려베포타스틴정(베포타스틴베실산염)2016-06-24
2 trial sites
- Bioequivalence디멘스타정(콜린알포세레이트)2016-04-29
2 trial sites
Show 6 more
- Bioequivalence벤라프렉스오알정75밀리그램(벤라팍신염산염)2016-02-26
2 trial sites
- Bioequivalence리포스토정 20밀리그램2014-12-23
2 trial sites
- Bioequivalence리포메트정20밀리그램(아토르바스타틴칼슘삼수화물)2014-03-19
2 trial sites
- Bioequivalence파비도엔필름코팅정 100mg/25mg/200mg2014-03-10
2 trial sites
- Bioequivalence시타프렉스정10밀리그램(에스시탈로프람옥살산염)2013-10-14
2 trial sites
- Bioequivalence듀로프렉스캡슐60밀리그램(둘록세틴염산염)2013-06-05
2 trial sites
R&D and key agreements
Source: DART corporate disclosure신약·제네릭·건강기능식품 연구개발 · R&D handled by seven teams including QM, research planning, and formulation research
Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1996 and listed on KOSDAQ in 1999, ChoA Pharmaceutical is an OTC-focused drugmaker exporting to 23 countries worldwide.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSPI-listed pharmaceutical company behind the combination drugs Amosartan (hypertension) and Rosuzet (dyslipidemia).
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
KOSPI-listed pharmaceutical company known for its anti-ulcer drug Noltec and leukemia treatment Supect (radotinib).
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
Kwangdong Pharmaceutical, founded in 1963 and KOSPI-listed in 1989, manufactures prescription drugs and beverages.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
Vivozon Pharmaceutical, founded in 2002 and KOSDAQ-listed in 2005, makes ETC/OTC drugs and runs CMO/OEM businesses across about 190 items.
Founded in 1926 and listed on the KOSPI in 1962, Yuhan Corporation is a comprehensive pharmaceutical company known for its innovative drug Leclaza.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition